These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2908327)

  • 1. [Effect of various beta-adrenolytic drugs and calcium channel blocker (nifedipine) on selected indicators of calcium-phosphorus metabolism in patients with hyperthyroidism and simple goiter].
    Gasińska T; Drózdz M; Izbicka M; Szydło E
    Endokrynol Pol; 1988; 39(6):327-37. PubMed ID: 2908327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of various beta-adrenolytic drugs and calcium channel blockers (nifedipine) on serum levels of T3 and T4 in patients with hyperthyroidism and simple goiter].
    Gasińska T; Nowak S; Izbicka M; Szydło E
    Endokrynol Pol; 1988; 39(3):119-27. PubMed ID: 2907475
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of various beta-adrenolytic drugs on heart rate and changes in left-ventricular systolic time intervals in patients with hyperthyroidism and simple goiter].
    Gasińska T; Nowak S; Prochaczek F; Izbicka M; Matuszewska-Radwańska J
    Endokrynol Pol; 1989; 40(2):69-78. PubMed ID: 2576401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acetylation phenotype and the changes in selected indicators of calcium-phosphate metabolism in patients with hyperthyroidism treated with propranolol].
    Gasińska T; Wawrzyniak L; Widala E
    Endokrynol Pol; 1989; 40(6):291-300. PubMed ID: 2485731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. I: Chemical quantities in serum and urine.
    Mosekilde L; Christensen MS; Melsen F; Sørensen NS
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):743-50. PubMed ID: 580520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of propranolol and indomethacin upon urinary hydroxyproline in hyperthyroid patients (author's transl)].
    Beylot M; Vincent M; Benzoni D; Bodson A; Riou JP; Mornex R
    Nouv Presse Med; 1982 Mar; 11(13):989-91. PubMed ID: 7070987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolism of collagen and hydroxprolinuria in thyroid diseases].
    Banno' S; Maggi GC; Buzzetti A
    Policlinico Prat; 1966 Nov; 73(47):1565-76. PubMed ID: 5998264
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disorders of bone metabolism in hyperthyroidism].
    Langer B
    Praxis; 1967 Jul; 56(30):1018-34. PubMed ID: 4180979
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phosphorus-calcium metabolism in hyperthyroidism].
    Popelier M; Jollivet B; Fouquet B; Lasfargues G; Valat C; Valat JP; Lecomte P
    Presse Med; 1990 Apr; 19(15):705-8. PubMed ID: 2139961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of propranolol in thyrotoxicosis. I. Nitrogen, calcium, and hydroxyproline.
    Georges LP; Santangelo RP; Mackin JF; Canary JJ
    Metabolism; 1975 Jan; 24(1):11-21. PubMed ID: 1110624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyproline excretion in the urine and calcium metabolism during long-term treatment of thyrotoxicosis with propylthiouracil.
    Siersbaek-Nielsen K; Skovsted L; Hansen JM; Kristensen M; Christensen LK
    Acta Med Scand; 1971 Jun; 189(6):485-8. PubMed ID: 5113863
    [No Abstract]   [Full Text] [Related]  

  • 12. [Calcium and inorganic phosphorus metabolism in diffuse toxic and nodular euthyroid goiter].
    Pirot K; Kuuz AL; Iadgarova NS
    Probl Endokrinol (Mosk); 1972; 18(2):49-53. PubMed ID: 5067406
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative response to parathyroid hormone in hyperthyroidism and hypothyroidism.
    Castro JH; Genuth SM; Klein L
    Metabolism; 1975 Jul; 24(7):839-48. PubMed ID: 1138158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H; Papapetrou PD
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of propranolol, atenolol and metoprolol on the serum levels of thyroxin (T4) and triiodothyronine (T3).
    Shikara MM; Maniar R; Steier W; Rao S; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():127. PubMed ID: 14699907
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antioxidant effect of drugs used in cardiovascular therapy].
    Silva JM; Filipe PM; Fernandes AC; Manso CF
    Rev Port Cardiol; 1998 Jun; 17(6):495-503. PubMed ID: 9677827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in various parameters of calcium-phosphorus metabolism, roentgenomorphometric indicators in selected bones and results of the calcitonin test in patients with hyperthyroidism].
    Gasińska T; Drozdz M; Izbicka M; Nawrat T; Beldzik A
    Endokrynol Pol; 1986; 37(2):75-84. PubMed ID: 3780573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.